Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Diabetologia|May 1, 1996
Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjectsN Paquot, P Schneiter, E Jéquier, et al.
Biochimie|March 30, 2001
Polarization of the Escherichia coli chromosome. A view from the terminusH Capiaux, F Cornet, J Corre, et al.
Acta Chirurgica Belgica|August 15, 2001
Amputations in diabetic patients: a plea for footsparing surgeryH Van Damme, M Rorive, B M Martens De Noorthout, et al.
Diabetes Care|July 1, 1984
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusionA Scheen, M Castillo, B Jandrain, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 1, 1992
Fluoxetine therapy in obese diabetic and glucose intolerant patientsM Kutnowski, J C Daubresse, H Friedman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1994
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patientsG Paolisso, A Scheen, D Cozzolino, et al.
Diabetologia|May 1, 1990
Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of ageG Paolisso, S Buonocore, S Gentile, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 29, 2006
Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional studyM De Hert, R van Winkel, D Van Eyck, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Belgian consensus on metabolic problems associated with atypical antipsychoticsA De Nayer, M De Hert, A Scheen, et al.
Acta Endocrinologica|December 1, 1981
Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjectsG Heynen, F Cornet, P Franchimont, et al.
Pageof 11